Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)

Name: Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)
Published: 2026
License: Public Domain

University of Illinois at Chicago · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

biomarkers fibrosis mri

iga nephropathy (igan), immunoglobulin a nephropathy (igan), iga nephropathy, atrasentan, multiparametric mri, mri, biomarkers, kidney injury, mechanistic, fibrosis, renal blood flow, kidney biopsy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 905241
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.